Conference abstractPublished 27 Jul 2015
Adult stem cell aging and skeletal regenerative medicine
Brigham and Women Hospital Harvard Medical School, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Regenerative potentials of many tissues are determined by the presence and functionality of adult stem and progenitor cells, which respond to exogenous cues to initiate tissue repair when needed. However, in many instances, resident adult stem/precursor cells suffer declining activity in response to aging, leading to reduced repair potential and chronic degenerative diseases. Human mesenchymal stem cells (MSCs) have been shown to be precursors of several different cellular lineages, including cartilage-forming chondrocytes and bone-forming osteoblasts. We reported that human marrow-derived MSCs show reproducible declines in proliferative and osteoblast potential with the age of the subject from whom the cells were obtained. Chemicals or drugs, which modulating endogenous MSCs, e.g. PTH and Vitamin D, have the potential to rejuvenate aged MSCs and to prevent or restore skeletal tissue degeneration and loss in the aging population. Tissue engineering approaches with adult stem cells have been applied clinically in cartilage and bone regeneration; however, more basic and translational researches as well as interactions between bench scientists and bedside clinicians are needed before tissue engineered biological organ replacement approaches with adult stem cells become standard clinical practice.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Shuanhu Zhou”